NDC 63323-311 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 63323-311 |
| Marketing Category | / |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-07-12 |
| Marketing End Date | 2018-08-31 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-09 |
| Marketing End Date | 2018-08-31 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-07-12 |
| Marketing End Date | 2016-02-29 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-09 |
| Marketing End Date | 2016-02-29 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-09 |
| Marketing End Date | 2018-08-31 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-07-12 |
| Marketing End Date | 2016-02-29 |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-08-09 |
| Marketing End Date | 2016-02-29 |